Logo for PMD Device Solutions

PMD Device Solutions Investor Relations Material

Latest events

Logo for PMD Device Solutions

Q4 2022

PMD Device Solutions
Logo for PMD Device Solutions

Q1 2024

28 May, 2024
Logo for PMD Device Solutions

Q4 2023

29 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from PMD Device Solutions

Access all reports
Promore Pharma AB, a biopharmaceutical company, develops therapeutic peptides for the bio-active wound care market in Sweden and internationally. The company offers Promogran Prisma, a collagen-based matrix; RESTORE collagen matrix, a synthetic medical device; PromoFoam matrix, a calcium alginate wound dressing; PAH250 Woundhance, a pharmaceutical agent used in the treatment of chronic wounds; and CytoMend, a resorbable extracellular matrix. It is also developing Platelet Rich Plasma (PRP), which has new functions for patients with chronic wounds; and Aktipak, which is indicated for treating acute deep wounds in conjunction with surgery/suture and debridement/wound bed preparation.